About this trial
The aim of this randomized controlled clinical trial is to evaluate the effects of a mindfulness-based self-efficacy development program on menopausal symptoms and quality of life in postmenopausal women. The main questions it aims to answer are:
Does the mindfulness-based program reduce the severity of menopausal symptoms?
Does the mindfulness-based program improve the quality of life of postmenopausal women?
Does the mindfulness-based program significantly increase participants' overall self-efficacy?
The researchers will compare whether there are differences between the mindfulness-based training program applied to the intervention group and the control group in terms of menopausal symptoms, quality of life, and self-efficacy scores.
The main tasks that will be asked of the participants are as follows:
Those in the intervention group will participate in a face-to-face mindfulness-based self-efficacy development program, each session lasting at least 120 minutes, once a week for 8 weeks, with a maximum of 10 people per group.
The control group will not receive any intervention.
Participants in both groups will be evaluated with a personal information form and measurement tools such as the Menopause Symptoms Assessment Scale, the Menopause Specific Quality of Life Scale, and the General Self-efficacy Scale.
Eligibility criteria
Qualifiers
Individuals who are in the +1a or +1b substage of early postmenopause according to the STRAW+10 system (at least 12 months and at most 24 months have passed since their last menstrual period)
Are proficient in reading and writing Turkish
Are in a spouse or partner
Have entered menopause naturally
Disqualifiers
Those who completed the pretest data collection forms incompletely,
Those who had any psychological disorder or experienced a traumatic event in the last two to one years,
Those who received hormone replacement therapy during menopause,
Those who had any gynecological cancer
Trial design
Treatments tested in this trial
- Mindfulness-Based Self-Efficacy Development Program
Treatment groups
Sponsors and collaborators
Nurcan Gökgöz
Lead sponsor
Lokman Hekim University
Sponsor institution